11-26-2018 03:10 PM CET - Health & Medicine
Print

Global Transfection Technologies Market 2018 Business Growth analysis with top players are Bio-Rad Laboratories, MaxCyte, Inc, Lonza, Miltenyi Biotec, QIAGEN, Polyplus-transfection S.A., Promega Corporation, Thermo Fisher Scientific, Agilent Technologies

Press release from: Data Bridge Market Research
Transfection Technologies shares
Transfection Technologies shares


Global Transfection Technologies Market Report for 2018 intends to offer target audience with the fresh outlook on market and fill in the knowledge gaps with the help of processed information and opinions from our industry experts. This research study released by Data Bridge Market Research evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The Transfection Technologies report is a comprehensive business study on the current state of industry which analyses innovative strategies for business growth and describes important factors such as top manufacturers, production value, key regions, and growth rate. Our report proposed the industry growth element coupled with the current scenario and projecting future trends based on historical and comprehensive research with Detailed Porter's Five Forces Analysis

The Transfection Technologies Market accounted to USD 547.02 million in 2016 growing at a CAGR of 10.3% during the forecast period of 2017 to 2024.

Read Comprehensive Overview | Instantly Available At databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Major Companies Covered

Prominent players operating in transfection technologies market are Bio-Rad Laboratories, MaxCyte, Inc., Lonza, Miltenyi Biotec, QIAGEN, Polyplus-transfection S.A., Promega Corporation, Thermo Fisher Scientific, Agilent Technologies, Altogen Biosystems, Boca Scientific Inc, chemicell Gmb, Harvard Bioscience, Takara Bio USA, Inc., Mirus Bio LLC, OriGene Technologies, PromoCell - premier manufacturer of human primary cells, OZ Biosciences, SIGNAGEN LABORATORIES LLC, Synvolux Therapeutics B.V., Precision NanoSystems Inc., Sino Biological Inc., System Biosciences among others.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: PIPELINE ANALYSIS

• Pipeline analysis

PART 06: MARKET SIZING

• Market definition
• Market sizing
• Market size and forecast

PART 07: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 08: MARKET SEGMENTATION

• Segmentation
• Comparison
• Market opportunity

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

• Geographical segmentation
• Regional comparison
• North America
• South America
• Europe
• MEA
• APAC
• Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

• Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 15: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors

PART 16: APPENDIX

• List of abbreviations

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Toc Is Available | Request At databridgemarketresearch.com/toc/?dbmr=global-transfectio...

Market Segmentation

By Applications the market is segmented into

• virus production,
protein production,
• gene silencing,
• stem cell reprogramming & differentiation and
• stable cell line generation

On the basis of geography, transfection technologies market report covers data points for 28 countries across multiple geographies such as

• North America & South America,
• Europe,
• Asia-Pacific, and
• Middle East & Africa

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

The transfection technologies market is segmented into

• cotransfection,
• electroporation,
• cationic lipid transfection and
• in vivo transfection

Why data bridge market research?

• Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report.

• Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report.

• Inimitable Expertise: Analysts will provide deep insights about the reports

• Assured Quality: We focus on the quality and accuracy of the report

• Technically acclaimed Analysts with complete industry know how Robust research methodology followed by our publishers to arrive at market estimates, Focus on technology trends, Extensive repository of market research reports to meet our client’s needs.

• Based on extensive research, we provide clear view of real market scenario and help clients with making informed business decisions

Get Expert’s Insights at databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Competitive Analysis:

The transfection technologies market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of transfection technologies market for global, Europe, North America, Asia Pacific and South America.

Major market drivers and Restraints:

• Rise in prevalence of obesity

• Emerging biopharmaceutical market

• Increasing demand for protein production

• Investments by government and private players

• Increasing incidences of cancer and infectious diseases

• Rise in research & development in the field of cell based therapies

• Risk with the cell of adverse reactions

• High price of transfection technology instruments

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1399538 • Views: 402
More releasesMore releases

You can edit or delete your press release here: